Norah Terrault, MD, MPH, on why few diagnosed patients reach HCV cure and how primary care test-and-treat can close the gap. AJMC: Your talk asks what the US should focus on to eliminate hepatitis C. Where do you see the biggest…
In England, 3 in 4 people with chronic liver disease first receive a diagnosis during an emergency hospital admission. In Nottinghamshire, GPs are trying to catch it earlier, with a scanner that turns up in libraries, leisure centres, and a roaming van.
A 72-year-old diabetic, obese man survived liver cancer after keyhole surgery. Doctors warn metabolic liver disease can progress silently to cirrhosis and cancer, urging early assessment and regular surveillance for at-risk patients. With diabetes, hypertension, obesity and cirrhosis complicating his…
Published October 29, 2026 | 04:15 PM The camp was organized under the Prime Minister’s National Hepatitis C Elimination Programme, with HEC Chairman Niaz Ahmad Akhtar joining students and organizers to promote early diagnosis and treatment. Chairman Higher Education Commission (HEC) Prof. Dr. Niaz…
Hepatitis, literally an inflammation of the liver, has several causes, including viral infection. The most common viruses are hepatitis A (HAV), hepatitis B (HBV), and hepatitis C (HCV). There is also... An update on the ABCs of viral hepatitis Hepatitis,…
Radiotherapy provided local disease control for patients with unresectable extrahepatic bile duct cancer, but tumour related complications remained a major contributor to mortality, according to a retrospective study. Most patients had perihilar bile duct cancer, and the median radiation dose…
The potential of induced pluripotent stem cells (iPSCs) for modeling and treating metabolic associated fatty liver disease (MAFLD) and metabolic associated steatohepatitis (MASH) is emerging. MAFLD is a growing global health concern, curren Induced pluripotent stem cell-derived mesenchymal stem cells…
UAB General Surgery research resident Tejeshwar Jain, M.D., was recognized for his project, "Targeting the gut microbiome improves anti-tumor cytotoxic CD8 T-cell response against hepatocellular carcinoma," which was nominated as one of the best hepatobiliary tract abstracts and will be presented at…
A new review of primary biliary cholangitis (PBC) has highlighted how interactions between immune cells and bile duct cells drive chronic inflammation, potentially leading to more personalised treatments. PBC is a chronic autoimmune disease that destroys small bile ducts inside…
A Phase 3 trial demonstrates superior survival with ivonescimab in advanced biliary tract cancer. Read more about the clinical findings. This site is intended for healthcare professionals Ivonescimab in Biliary Tract Cancer Outperforms Standard Care - Ivonescimab plus chemotherapy extended median overall…
Liver and bile duct cancer: causes such as hepatitis, fatty liver and alcohol, diagnosis and treatment.
An article joins this feed when it matches these terms. Each one is also a search of its own.